hengrui glp-1 obesity #type2diabetes #glp1 #clinicaltrials #phase3 #biotech #pharma #drugdevelopment #healthcareinnovation #lifesciences #metabolichealth #pharmaceuticalindustry Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1

There is strong evidence that the endogenous and exogenous reactive oxygen and nitrogen species play a major role in the airway inflammation and are determinants of asthma severity[16] (Figure 1)

I was presenting a poster there

GLP-1 stimulates the release of glucose-dependent insulin secretions, slows the movements of the intestinal tract, as well as the emptying of the stomach[3]

Or, read our expert answers to commonly asked questions about GLP-1

Getting Around An Array of Side Effects While GLP-1 holds promise as a weight loss aid, addressing potential side effects is vital

How long does it take to see results from BPC-157